Malignant hemopathies and tumor lysis syndrome: a current topic

Saved in:
Bibliographic Details
Published in:Archives de pédiatrie : organe officiel de la Société française de pédiatrie 2005-10, Vol.12 Spec No 1, p.1
Main Authors: Leverger, G, Le Guyader, N
Format: Article
Language:fre
Subjects:
Antimetabolites - therapeutic use
Antineoplastic Agents - adverse effects
Child
Hematologic Neoplasms - drug therapy
Humans
Recombinant Proteins
Tumor Lysis Syndrome - drug therapy
Tumor Lysis Syndrome - etiology
Urate Oxidase - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 1
container_title Archives de pédiatrie : organe officiel de la Société française de pédiatrie
container_volume 12 Spec No 1
creator Leverger, G
Le Guyader, N
description
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_17076002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17076002</sourcerecordid><originalsourceid>FETCH-LOGICAL-p542-7efdfb60b134eee70e0ace150a534cf8882c91e1d626f7a57d059c1fdaa30fcf3</originalsourceid><addsrcrecordid>eNo1j7tOwzAUQD2A2lL6C8g_EOnajmOHBaGKR6Uilg5s1Y19TYPiJLKTIX8PEjCd5ehI54ptoJZ1UdXqY81ucv4CAAtWrdhaGDAVgNywhzfs2s8e-4lfKA4jTpeWMsfe82mOQ-LdktvM89L7NES658jdnBL9-NMwtu6WXQfsMu3-uGWn56fT_rU4vr8c9o_HYtSlLAwFH5oKGqFKIjJAgI6EBtSqdMFaK10tSPhKVsGgNh507UTwiAqCC2rL7n6z49xE8ucxtRHTcv4fUd9mSUTg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Malignant hemopathies and tumor lysis syndrome: a current topic</title><source>ScienceDirect Journals</source><creator>Leverger, G ; Le Guyader, N</creator><creatorcontrib>Leverger, G ; Le Guyader, N</creatorcontrib><identifier>ISSN: 0929-693X</identifier><identifier>PMID: 17076002</identifier><language>fre</language><publisher>France</publisher><subject>Antimetabolites - therapeutic use ; Antineoplastic Agents - adverse effects ; Child ; Hematologic Neoplasms - drug therapy ; Humans ; Recombinant Proteins ; Tumor Lysis Syndrome - drug therapy ; Tumor Lysis Syndrome - etiology ; Urate Oxidase - therapeutic use</subject><ispartof>Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2005-10, Vol.12 Spec No 1, p.1</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17076002$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leverger, G</creatorcontrib><creatorcontrib>Le Guyader, N</creatorcontrib><title>Malignant hemopathies and tumor lysis syndrome: a current topic</title><title>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</title><addtitle>Arch Pediatr</addtitle><subject>Antimetabolites - therapeutic use</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Child</subject><subject>Hematologic Neoplasms - drug therapy</subject><subject>Humans</subject><subject>Recombinant Proteins</subject><subject>Tumor Lysis Syndrome - drug therapy</subject><subject>Tumor Lysis Syndrome - etiology</subject><subject>Urate Oxidase - therapeutic use</subject><issn>0929-693X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNo1j7tOwzAUQD2A2lL6C8g_EOnajmOHBaGKR6Uilg5s1Y19TYPiJLKTIX8PEjCd5ehI54ptoJZ1UdXqY81ucv4CAAtWrdhaGDAVgNywhzfs2s8e-4lfKA4jTpeWMsfe82mOQ-LdktvM89L7NES658jdnBL9-NMwtu6WXQfsMu3-uGWn56fT_rU4vr8c9o_HYtSlLAwFH5oKGqFKIjJAgI6EBtSqdMFaK10tSPhKVsGgNh507UTwiAqCC2rL7n6z49xE8ucxtRHTcv4fUd9mSUTg</recordid><startdate>200510</startdate><enddate>200510</enddate><creator>Leverger, G</creator><creator>Le Guyader, N</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200510</creationdate><title>Malignant hemopathies and tumor lysis syndrome: a current topic</title><author>Leverger, G ; Le Guyader, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p542-7efdfb60b134eee70e0ace150a534cf8882c91e1d626f7a57d059c1fdaa30fcf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2005</creationdate><topic>Antimetabolites - therapeutic use</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Child</topic><topic>Hematologic Neoplasms - drug therapy</topic><topic>Humans</topic><topic>Recombinant Proteins</topic><topic>Tumor Lysis Syndrome - drug therapy</topic><topic>Tumor Lysis Syndrome - etiology</topic><topic>Urate Oxidase - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leverger, G</creatorcontrib><creatorcontrib>Le Guyader, N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leverger, G</au><au>Le Guyader, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Malignant hemopathies and tumor lysis syndrome: a current topic</atitle><jtitle>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</jtitle><addtitle>Arch Pediatr</addtitle><date>2005-10</date><risdate>2005</risdate><volume>12 Spec No 1</volume><spage>1</spage><pages>1-</pages><issn>0929-693X</issn><cop>France</cop><pmid>17076002</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0929-693X
ispartof Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2005-10, Vol.12 Spec No 1, p.1
issn 0929-693X
language fre
recordid cdi_pubmed_primary_17076002
source ScienceDirect Journals
subjects Antimetabolites - therapeutic use
Antineoplastic Agents - adverse effects
Child
Hematologic Neoplasms - drug therapy
Humans
Recombinant Proteins
Tumor Lysis Syndrome - drug therapy
Tumor Lysis Syndrome - etiology
Urate Oxidase - therapeutic use
title Malignant hemopathies and tumor lysis syndrome: a current topic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A05%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Malignant%20hemopathies%20and%20tumor%20lysis%20syndrome:%20a%20current%20topic&rft.jtitle=Archives%20de%20p%C3%A9diatrie%20:%20organe%20officiel%20de%20la%20Soci%C3%A9t%C3%A9%20fran%C3%A7aise%20de%20p%C3%A9diatrie&rft.au=Leverger,%20G&rft.date=2005-10&rft.volume=12%20Spec%20No%201&rft.spage=1&rft.pages=1-&rft.issn=0929-693X&rft_id=info:doi/&rft_dat=%3Cpubmed%3E17076002%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p542-7efdfb60b134eee70e0ace150a534cf8882c91e1d626f7a57d059c1fdaa30fcf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/17076002&rfr_iscdi=true